Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 3
2005 3
2006 2
2007 3
2008 2
2009 2
2010 4
2011 2
2012 3
2013 3
2014 6
2015 4
2016 7
2017 8
2018 1
2019 7
2020 9
2021 9
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Behind the IL-8 ball in prostate cancer.
Madan RA, Palena C. Madan RA, et al. Among authors: palena c. Nat Cancer. 2021 Aug;2(8):775-776. doi: 10.1038/s43018-021-00235-3. Nat Cancer. 2021. PMID: 35122026 No abstract available.
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.
DeMaria PJ, Lee-Wisdom K, Donahue RN, Madan RA, Karzai F, Schwab A, Palena C, Jochems C, Floudas C, Strauss J, Marté JL, Redman JM, Dombi E, Widemann B, Korchin B, Adams T, Pico-Navarro C, Heery C, Schlom J, Gulley JL, Bilusic M. DeMaria PJ, et al. Among authors: palena c. J Immunother Cancer. 2021 Sep;9(9):e003238. doi: 10.1136/jitc-2021-003238. J Immunother Cancer. 2021. PMID: 34479925 Free PMC article. Clinical Trial.
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.
Li D, Schaub N, Guerin TM, Bapiro TE, Richards FM, Chen V, Talsania K, Kumar P, Gilbert DJ, Schlomer JJ, Kim SJ, Sorber R, Teper Y, Bautista W, Palena C, Ock CY, Jodrell DI, Pate N, Mehta M, Zhao Y, Kozlov S, Rudloff U. Li D, et al. Among authors: palena c. Mol Cancer Ther. 2021 Oct;20(10):1926-1940. doi: 10.1158/1535-7163.MCT-20-0620. Epub 2021 Aug 10. Mol Cancer Ther. 2021. PMID: 34376576 Free PMC article.
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
Bilusic M, McMahon S, Madan RA, Karzai F, Tsai YT, Donahue RN, Palena C, Jochems C, Marté JL, Floudas C, Strauss J, Redman J, Abdul Sater H, Rabizadeh S, Soon-Shiong P, Schlom J, Gulley JL. Bilusic M, et al. Among authors: palena c. J Immunother Cancer. 2021 Mar;9(3):e002374. doi: 10.1136/jitc-2021-002374. J Immunother Cancer. 2021. PMID: 33762322 Free PMC article. Clinical Trial.
77 results